Supernus Pharmaceuticals, Inc. (SUPN) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, and thank you for standing by. Welcome to the Supernus Pharmaceuticals Second Quarter 2025 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. Instructions will follow at that time. Please be advised that today's conference is being recorded. I would now like to turn the conference over to your first speaker today, Peter Vazzo of ICR Healthcare, Investor Relations Representative for Supernus Pharmaceuticals. You may begin. Thank you, Gerald. Good afternoon, everyone, and thank you for joining us today for Sopernos Pharmaceuticals' second quarter 2025 financial results conference call. Today, after the closed market, the company issued a press release announcing these results. On the call with me today are Sopernos' Chief Executive Officer, Jack Katar, and Chief Financial Officer, Tim Deff. This call is being made available via the investor relations section of the company's website at ir.sopernos.com. During the course of this call, management may make certain forward-looking statements regarding future events and the company's future performance. These forward-looking statements reflect the firm's current perspective on existing trends and information. Any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, including those noted in the risk factor section of the company's latest SEC filings. Actual results may differ materially from those suggested in these forward-looking statements. For the benefit of those of you who may be listening to the replay, this call is being held and recorded on August 5th, 2025. Since then, the company may have made additional announcements related to ...